L Giovanella, D Deandreis, A Vrachimis, A Campenni… - Cancers, 2022 - mdpi.com
Simple Summary According to the American Cancer Society, approximately 53,000 new cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …
Introduction Scintigraphic evaluation of the thyroid gland enables determination of the iodine- 123 iodide or the 99m Tc-pertechnetate uptake and distribution and remains the most …
PR Jermain, M Oswald, T Langdun, S Wright… - Scientific Reports, 2024 - nature.com
Fluorescence polarization (Fpol) imaging of methylene blue (MB) is a promising quantitative approach to thyroid cancer detection. Clinical translation of MB Fpol technology requires …
Simple Summary Thyroid nodules are commonly detected in daily clinical practice, and their diagnosis and therapy usually involve different specialists and various diagnostic and …
O Rager, P Radojewski, RA Dumont, G Treglia… - Gland …, 2019 - ncbi.nlm.nih.gov
The risk of malignancy in thyroid nodules with indeterminate cytological classification (Bethesda III–IV) ranges from 10% to 40%, and early delineation is essential as delays in …
I Iakovou, E Giannoula, C Sachpekidis - Journal of clinical medicine, 2020 - mdpi.com
Thyroid nodules are less frequent in children than adults. Childhood thyroid nodules carry specific features, including a higher risk of malignancy than nodules in adults, rendering …
TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland, accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …
The literature on Galectin-3 (Gal-3) was systematically reviewed to achieve more robust information on its histologic reliability in identifying thyroid cancers and on the concordance …
H Benderradji, A Beron, JL Wémeau, B Carnaille… - Annales d' …, 2021 - Elsevier
Background The aim of this study was to evaluate the role of dual isotope 123 Iodine/99m Tc- MIBI thyroid scintigraphy (IMS) in discriminating between malignant and benign lesions in …